Current Developments of N-Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment

被引：27

作者：

Tialiou, Alexia ^{[1
,2
]}

Chin, Jiamin ^{[3
]}

Keppler, Bernhard K. ^{[1
,4
,5
]}

Reithofer, Michael R. ^{[1
]}

机构：

[1] Univ Vienna, Fac Chem, Inst Inorgan Chem, Wahringer Str 42, A-1090 Vienna, Austria

[2] Univ Vienna, Vienna Doctoral Sch Chem DoSChem, Wahringer Str 42, A-1090 Vienna, Austria

[3] Univ Vienna, Inst Inorgan Chem Funct Mat, Fac Chem, Wahringer Str 42, A-1090 Vienna, Austria

[4] Univ Vienna, Res Cluster Translat Canc Therapy Res, Wahringer Str 42, A-1090 Vienna, Austria

[5] Med Univ Vienna, Wahringer Str 42, A-1090 Vienna, Austria

来源：

BIOMEDICINES | 2022年 / 10卷 / 06期

基金：

奥地利科学基金会;

关键词：

cancer; gold complexes; N-heterocyclic carbenes; NHC; DNA; G-quadruplex; G-QUADRUPLEX; GOLD(III) COMPLEXES; HISTORY LANDMARKS; METAL-COMPLEXES; GOLD COMPOUNDS; DNA; CHEMISTRY; NHC; LIGANDS; BINDING;

D O I：

10.3390/biomedicines10061417

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Since their first discovery, N-heterocyclic carbenes have had a significant impact on organometallic chemistry. Due to their nature as strong sigma-donor and pi-acceptor ligands, they are exceptionally well suited to stabilize Au(I) and Au(III) complexes in biological environments. Over the last decade, the development of rationally designed NHCAu(I/III) complexes to specifically target DNA has led to a new "gold rush" in bioinorganic chemistry. This review aims to summarize the latest advances of NHCAu(I/III) complexes that are able to interact with DNA. Furthermore, the latest advancements on acyclic diamino carbene gold complexes with anticancer activity are presented as these typically overlooked NHC alternatives offer great additional design possibilities in the toolbox of carbene-stabilized gold complexes for targeted therapy.

引用

页数：26

共 154 条

[1] In vitro Biological Activities of Gold(I) and Gold(III) Bis (N-Heterocyclic Carbene) Complexes
Al-Majid, Abdullah M.
Choudhary, Muhammad Iqbal
Yousuf, Sammer
Jabeen, Almas
Imad, Rehan
Javeed, Kulsoom
Shaikh, Nimra Naveed
Collado, Alba
Sioriki, Eleni
Nahra, Fady
Nolan, Steven P.
[J]. CHEMISTRYSELECT, 2017, 2 (19): : 5316 - 5320
[2] Alessio E., 2011, BIOINORGANIC MED CHE
[3] [Anonymous], 2016, MEYLERS SIDE EFFECTS, V16th
[4] Avendano CarmenMenendez J. Carlos., 2015, Medicinal Chemistry of Anticancer Drugs
[5] Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer
Bakewell, Suzanne
Conde, Isabel
Fallah, Yassi
McCoy, Mathew
Jin, Lu
Shajahan-Haq, Ayesha N.
[J]. CANCERS, 2020, 12 (09) : 1 - 19
[6] G-quadruplex nucleic acids as therapeutic targets
Balasubramanian, Shankar
Neidle, Stephen
[J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2009, 13 (03) : 345 - 353
[7] Gold-based therapy: From past to present
Balfourier, Alice
Kolosnjaj-Tabi, Jelena
Luciani, Nathalie
Carn, Florent
Gazeau, Florence
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (37) : 22639 - 22648
[8] Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation
Bazzicalupi, Carla
Ferraroni, Marta
Papi, Francesco
Massai, Lara
Bertrand, Benoit
Messori, Luigi
Gratteri, Paola
Casini, Angela
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (13) : 4256 - 4259
[9] Berners-Price SJ, 2014, LIGAND DESIGN IN MEDICINAL INORGANIC CHEMISTRY, P227
[10] Bernstein LR, 1998, PHARMACOL REV, V50, P665

← 1 2 3 4 5 6 7 8 9 10 →